Does Dr. FRANCIS ALLINSON have financial conflicts of interest?

Dr. FRANCIS ALLINSON (MD) has received a total of $2,158 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $2,158 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. FRANCIS ALLINSON?

According to CMS Open Payments data, Dr. FRANCIS ALLINSON received funding from ZOLL SERVICES (A/K/A ZOLL LIFECOR ) ($844), NOVARTIS PHARMACEUTICALS CORPORATION ($346), and ABBOTT LABORATORIES ($293).

Does Dr. FRANCIS ALLINSON receive research grants or speaking fees?

Dr. FRANCIS ALLINSON has received $2,158 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. FRANCIS ALLINSON

MDReal-Time Hydrated

Specialty: Internal Medicine, Cardiovascular Disease

Practice Location: LA JOLLA, CA 92037

NPI Number: 1679062707

LIFETIME INDUSTRY VALUE

$2,158

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. ALLINSON is a verified Internal Medicine, Cardiovascular Disease practitioner based in LA JOLLA, CA.

Between 2021 and 2024, Dr. ALLINSON had an overall industry promotional and research financial footprint of $2,158 as recorded in the federal CMS Open Payments database.

$2,158 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ALLINSON's primary funding source is ZOLL SERVICES (A/K/A ZOLL LIFECOR ), which accounts for $844 (representing 39.1% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

ZOLL SERVICES (A/K/A ZOLL LIFECOR )

Rank 1

$844

39.1%

NOVARTIS PHARMACEUTICALS CORPORATION

Rank 2

$346

16%

ABBOTT LABORATORIES

Rank 3

$293

13.6%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.